Expand AFMD Menu
AFMD MENU

About AFMD

Affimed (AFMD) is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. Affimed's product candidates are being developed in the field of immuno-oncology, which represents an innovative approach to cancer treatment that seeks to harness the body's own immune defenses to fight tumor cells. The most potent cells of the human defense arsenal are types of white blood cells called natural killer cells, or NK-cells, and T-cells. Affimed's proprietary, next-generation bispecific antibodies, called TandAbs for their tandem antibody structure, are designed to direct and establish a bridge between either NK-cells or T-cells and cancer cells, triggering a signal cascade that leads to the destruction of cancer cells. Affimed has focused its research and development efforts on three proprietary TandAb programs for which it retains global commercial rights.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

AFMD is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
VTHR Vanguard Russell 3000 ETF 487.1 M 4.871E+08 2,947 2947 0.0% 7.28392E-06 4 K 3583
VTWG Vanguard Russell 2000 Growth ETF 342.7 M 3.427E+08 1,175 1175 0.02% 0.000150531 53 K 53370
VTWV Vanguard Russell 2000 Value ETF 294.2 M 2.942E+08 1,404 1404 0.0% 3.61139E-05 11 K 10754
IBB iShares Nasdaq Biotechnology Index Fund 7.4 B 7.44998E+09 215 215 0.03% 0.0003 2.0 M 1974270
IWC iShares Microcap ETF 879.6 M 8.79571E+08 1,391 1391 0.06% 0.0006 500 K 499989
IWM iShares Russell 2000 ETF 46.8 B 4.68463E+10 1,992 1992 0.01% 0.0001 4.7 M 4692140
IWN iShares Russell 2000 Value ETF 9.8 B 9.75753E+09 1,398 1398 0.0% 0 390 K 390067
IWO iShares Russell 2000 Growth ETF 10.1 B 1.00763E+10 1,167 1167 0.02% 0.0002 1.6 M 1613870
IWV iShares Russell 3000 ETF 10.5 B 1.04911E+10 2,885 2885 0.0% 0 94 K 93751
BIB ProShares Ultra Nasdaq Biotechnology 175.2 M 1.752E+08 226 226 0.01% 0.000105709 40 K 39942
UBIO Proshares UltraPro Nasdaq Biotechnology 26.0 M 2.59633E+07 221 221 0.01% 6.41436E-05 5 K 5382
URTY ProShares UltraPro Russell2000 96.6 M 9.6556E+07 2,003 2003 0.0% 2.59773E-05 8 K 7978
UWM ProShares Ultra Russell2000 215.8 M 2.15812E+08 2,003 2003 0.0% 4.43585E-05 20 K 19949